Accelerating the delivery of new drugs to patients

Glasgow based project ran by The University of Strathclyde and Glasgow School of Art, ARTICULAR, has received a grant of £1.9 million.

The funding has been awarded to ARTICULAR, a project which will use advances in digital technology to help reduce the time it takes to get new drugs to market by harnessing the potential of large data sets and Machine Learning – techniques which enable computers to improve performance progressively on a specific task. The grant has been made by the Engineering and Physical Sciences Research Council (EPSRC).

It is currently difficult to avoid ‘starting at the beginning’ for every new drug that needs to be manufactured but new medicines are currently doubling in cost every nine years. ARTICULAR seeks to develop novel machine learning approaches that learn from past and present manufacturing data to create new knowledge that aids in crucial manufacturing decisions and lead to higher quality medicines for patients.

This highlights Scotland as a centre of innovation and cutting-edge research. Read more about this in Scotland’s life sciences sector here. 

Read the full article, here.